Comment
Disease-free survival was greater with letrozole than tamoxifen in postmenopausal women with early breast cancer
Affiliations
- PMID: 16813359
Item in Clipboard
Comment
Disease-free survival was greater with letrozole than tamoxifen in postmenopausal women with early breast cancer
ACP J Club.
2006 Jul-Aug.
No abstract available
Comment on
-
A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer.N Engl J Med. 2005 Dec 29;353(26):2747-57. doi: 10.1056/NEJMoa052258. N Engl J Med. 2005. PMID: 16382061 Clinical Trial.
Similar articles
-
Cost-effectiveness of letrozole versus tamoxifen as initial adjuvant therapy in postmenopausal women with hormone-receptor positive early breast cancer from a Canadian perspective.Breast Cancer Res Treat. 2008 Apr;108(3):375-87. doi: 10.1007/s10549-007-9607-7. Epub 2007 Jul 26. Breast Cancer Res Treat. 2008. PMID: 17653859 Clinical Trial.
-
Efficacy, toxicity, and quality of life in older women with early-stage breast cancer treated with letrozole or placebo after 5 years of tamoxifen: NCIC CTG intergroup trial MA.17.J Clin Oncol. 2008 Apr 20;26(12):1956-64. doi: 10.1200/JCO.2007.12.6334. Epub 2008 Mar 10. J Clin Oncol. 2008. PMID: 18332474 Clinical Trial.
-
Beyond tamoxifen: extended and late extended endocrine therapy in postmenopausal early breast cancer.Cancer Treat Rev. 2008 Apr;34(2):137-44. doi: 10.1016/j.ctrv.2007.09.004. Epub 2007 Nov 14. Cancer Treat Rev. 2008. PMID: 18006236 Review.
-
Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98.J Clin Oncol. 2007 Feb 10;25(5):486-92. doi: 10.1200/JCO.2006.08.8617. Epub 2007 Jan 2. J Clin Oncol. 2007. PMID: 17200148 Clinical Trial.
-
Understanding the BIG results: Insights from the BIG 1-98 trial analyses.Adv Ther. 2008 Dec;25(12):1257-75. doi: 10.1007/s12325-008-0128-5. Adv Ther. 2008. PMID: 19096768 Review.